News

RFK Jr. recently made major cuts to mRNA vaccine development research, questioning their safety. Should you still get the ...
The Nobel Prize-winning technology underpinning COVID-19 vaccines is also fueling a host of biotechs developing treatments ...
CAMBRIDGE, MA / ACCESS Newswire / August 1, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the UK Court of Appeal ...
HHS is slashing hundreds of millions in funding for mRNA vaccines and infectious disease treatments, but leaving the door ...
The top public health officials during Trump's first term praised mRNA vaccines. In the second term, officials seem to be ...
U.S. Health and Human Services Secretary Robert F. Kennedy Jr. announced last week that his department would slash about $500 ...
On August 1, 2025, a UK Court of Appeal upheld the validity of Moderna’s European Patent No. 3,590,949 (“EP’949”) in a dispute with Pfizer ...
The average short interest in the S&P 500 Health Care Index Sector (XLV) dipped slightly in July to 1.95% from 1.96% in June.
The U.S. health secretary ordered an end to new mRNA development efforts just after UTMB published new research showing its ...
Shares of the biotech Moderna were up on Wednesday, as the Trump administration’s shifting position on messenger RNA-based ...
Moderna (MRNA) skyrocketed to fame during the pandemic, delivering one of the first mRNA-based Covid-19 vaccines and quickly ...